| Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade (NCT04984018) | The First Affiliated Hospital of Zhengzhou University | 2021-12-01 |
| Assessing a Clinically-meaningful Opioid Withdrawal Phenotype (NCT05027919) | University of Maryland, Baltimore | 2021-12-01 |
| Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations (NCT06471686) | University of Southern California | 2021-12-01 |
| Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL (NCT05252403) | Fondazione Matilde Tettamanti Menotti De Marchi Onlus | 2021-12-01 |
| Redefining Survivorship: POWER to Maximize Physical Function for Survivors of Critical Illness (NCT04058977) | Kirby Mayer | 2021-12-01 |
| Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma (NCT04689659) | Beijing Boren Hospital | 2021-12-01 |
| Oxytocin Pharmacokinetics After Intramuscular Injection (NCT04427540) | Wake Forest University Health Sciences | 2021-12-01 |
| Tumescent Anesthesia Antibiotic Delivery (TAAD) (NCT03226626) | HK Surgical, Inc. | 2021-12-01 |
| Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL (NCT04334408) | Mayo Clinic | 2021-12-01 |
| Evaluation of a Folic Acid Wound Treatment (FAWT) for Chronic, Early-Stage Diabetic Foot Ulcer (DFU) Healing (NCT04723134) | Joseph Boykin, MD | 2021-12-01 |
| Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC (NCT04819971) | The First Affiliated Hospital of Zhengzhou University | 2021-12-01 |
| Effect of Intravenous Dexamethasone on Duration of Hyperbaric Bupivacaine Spinal Anesthesia in Lower Abdominal Surgery (NCT04778189) | Assiut University | 2021-12-01 |
| A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML) (NCT05100303) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-12-01 |
| Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery (NCT05398081) | Dr. Promise Tamunoipiriala Jaja | 2021-12-01 |
| Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure (NCT05126186) | Assistance Publique - Hôpitaux de Paris | 2021-12-01 |
| Sit Less, Interact and Move More (SLIMM) 2 Study (NCT05173714) | Srinvasan Beddhu | 2021-12-01 |
| A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC (NCT04514835) | The First Affiliated Hospital of Zhengzhou University | 2021-12-01 |
| Value of ctDNA in the Treatment of Multiple Primary Cancers (NCT05164510) | Fudan University | 2021-12-01 |
| Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer (NCT04390945) | The First Affiliated Hospital of Henan University of Science and Technology | 2021-12-01 |
| Abemaciclib + Pembrolizumab In Glioblastoma (NCT04118036) | Dana-Farber Cancer Institute | 2021-12-01 |
| COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines (NCT04845191) | ImmunityBio, Inc. | 2021-12-01 |
| Zinc Containing Vaginal Topical " Suppository " (NCT05453227) | Egymedicalpedia | 2021-12-01 |
| Fatty Acid Supplementation in Children With ASD (Study 2) (NCT04312932) | Sarah Keim | 2021-12-01 |
| IV Acetaminophen and Post-Tonsillectomy Pain (NCT03883893) | Children's Hospital Medical Center, Cincinnati | 2021-12-01 |
| Effect of Topically Administered Levobupivacaine- Fentanyl Versus Levobupivacaine- Dexamethasone Combination in the Control of Pain After Endoscopic Sinus Surgery (NCT05145543) | Assiut University | 2021-12-01 |
| Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis (NCT03983252) | Brigham and Women's Hospital | 2021-12-01 |
| Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke (NCT04890353) | Xuanwu Hospital, Beijing | 2021-12-01 |
| A Study of Orelabrutinib in Patients With ITP (NCT05124028) | Peking University People's Hospital | 2021-12-01 |
| Milrinone Versus Placebo in Patients With Septic Shock (NCT05122884) | Mahidol University | 2021-12-01 |
| The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma (NCT03928275) | Carman Giacomantonio | 2021-12-01 |
| A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC (NCT05262959) | Shanghai Zhongshan Hospital | 2021-12-01 |
| Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources (NCT05196581) | Suzana Erico Tanni Minamoto | 2021-12-01 |
| LIpitor and biGuanide to Androgen Delay Trial (NCT02497638) | University Health Network, Toronto | 2021-12-01 |
| Avatrombopag to Promote Platelet Engraftment After Allo-HSCT (NCT05143892) | The First Affiliated Hospital of Soochow University | 2021-12-01 |
| Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer (NCT05170581) | The Second Affiliated Hospital of Shandong First Medical University | 2021-12-01 |
| Sirtuin-NAD Activator in Alzheimer's Disease (NCT05040321) | Brigham and Women's Hospital | 2021-12-01 |
| Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer (NCT05034055) | Yonsei University | 2021-12-01 |
| Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19) (NCT05087368) | D'Or Institute for Research and Education | 2021-12-01 |
| 68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer (NCT05160051) | University Hospital, Essen | 2021-12-01 |
| Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen (NCT05088226) | Chinese PLA General Hospital | 2021-12-01 |
| Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children (NCT05313958) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-12-01 |
| A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) (NCT05060016) | Amgen | 2021-12-01 |
| Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma (NCT05021770) | Huiqiang Huang | 2021-12-01 |
| Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC (NCT05207371) | GAIA BioMedicine Inc. | 2021-12-01 |
| Mindful Self-Compassion (MSC) for Infertility Related Distress (NCT05183568) | University of Regina | 2021-12-01 |
| umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN) (NCT05100212) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-12-01 |
| Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial (NCT04825197) | VENTO GIOVANNI | 2021-12-01 |
| A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen (NCT05138159) | Fudan University | 2021-12-01 |
| MAP4343 Treatment for Alcohol Use Disorder (NCT04157114) | The Scripps Research Institute | 2021-12-01 |
| A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease. (NCT04263519) | Massachusetts General Hospital | 2021-12-01 |
| Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma (NCT05166772) | Tianjin Medical University Cancer Institute and Hospital | 2021-12-01 |
| Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis (NCT05092646) | Axolotl Biologix | 2021-12-01 |
| Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke (NCT04890366) | Xuanwu Hospital, Beijing | 2021-12-01 |
| Comparison Between Retrolaminar and Medial Branch Block in Cervical Facet Joint Arthropathy (NCT05184881) | Mansoura University | 2021-12-01 |
| Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial (NCT05144100) | Tata Memorial Centre | 2021-12-01 |
| 68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma (NCT05902377) | Peking Union Medical College Hospital | 2021-12-01 |
| A Study of Carilizumab Combined With Concurrent Chemoradiotherapy (NCT05151549) | Hunan Cancer Hospital | 2021-12-01 |
| Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT (NCT04118556) | Mats Remberger | 2021-12-01 |
| Insulin Resistance and Androgen Deprivation Therapy (NCT04995978) | St. Louis University | 2021-12-01 |
| The Multicenter Topic Trial (NCT04066751) | University of Alabama at Birmingham | 2021-12-01 |
| The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (NCT05167851) | Yonsei University | 2021-12-01 |
| Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy (NCT04816526) | Cartesian Therapeutics | 2021-12-01 |
| Minocycline for Chronic Autoimmune Uveitis (NCT05474729) | Sun Yat-sen University | 2021-12-01 |
| US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies (NCT04990323) | ExCellThera inc. | 2021-12-01 |
| Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients (NCT05136833) | Archivel Farma S.L. | 2021-12-01 |
| Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) (NCT05136768) | Jun-Lin Yi, MD | 2021-12-01 |
| Safety and Tuberculin Conversion Following BCG Vaccination (NCT05124340) | PT Bio Farma | 2021-12-01 |
| Anakinra, COVID-19, Cytokine Storm (NCT04603742) | Weill Medical College of Cornell University | 2021-12-01 |
| A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19) (NCT05115019) | PT. Innovative Pharma Solutions | 2021-12-01 |
| A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer (NCT04308785) | Hoffmann-La Roche | 2021-12-01 |
| COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines (NCT04843722) | ImmunityBio, Inc. | 2021-12-01 |
| Cycled Testosterone Administration During Pulmonary Rehabilitation in Early Stage COPD (NCT03674320) | The University of Texas Medical Branch, Galveston | 2021-12-01 |
| TAK-242 in Patients With Acute Alcoholic Hepatitis (NCT04620148) | Akaza Bioscience Ltd | 2021-12-01 |
| A Study of MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung Cancer (NSCLC). (NCT05141786) | Shanghai Miracogen Inc. | 2021-12-01 |
| Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram (NCT05847257) | Al-Mustansiriyah University | 2021-12-01 |
| Tislelizumab in Addition to BACE in Patients with NSCLC (NCT05058560) | The First Affiliated Hospital of Zhengzhou University | 2021-12-01 |
| Curcumin in Advanced Cervical Cancer (NCT04294836) | Instituto Nacional de Cancerologia, Columbia | 2021-12-01 |
| Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001) (NCT05262335) | Ruijin Hospital | 2021-12-01 |
| Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy (NCT06074029) | Peking Union Medical College Hospital | 2021-12-01 |
| Rituxmab Versus IL-6 in Treating ILD (NCT05963048) | Assiut University | 2021-12-01 |
| A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets (NCT04950166) | OncoNano Medicine, Inc. | 2021-11-30 |
| A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis (NCT05235269) | Attralus, Inc. | 2021-11-30 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis (NCT05090904) | Insmed Incorporated | 2021-11-30 |
| A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors (NCT05134948) | Bristol-Myers Squibb | 2021-11-30 |
| DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway (NCT04963231) | Rhythm Pharmaceuticals, Inc. | 2021-11-30 |
| A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors (NCT05093322) | Hutchmed | 2021-11-30 |
| A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia (NCT04874350) | Lipocine Inc. | 2021-11-30 |
| Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection (NCT04560569) | Frontier Biotechnologies Inc. | 2021-11-30 |
| Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer (NCT05171387) | Bayer | 2021-11-30 |
| Mirabegron and Physiological Function in Cold Environments (NCT04766021) | Indiana University | 2021-11-30 |
| Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD (NCT05165394) | Neurocrine Biosciences | 2021-11-30 |
| Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy (NCT05110768) | Rockwell Medical Technologies, Inc. | 2021-11-30 |
| A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer (NCT04916002) | Regeneron Pharmaceuticals | 2021-11-30 |
| A Safety and Efficacy Trial of TTHX1114 in People With CED (NCT04812067) | Trefoil Therapeutics, Inc. | 2021-11-30 |
| A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer (NCT05125016) | Regeneron Pharmaceuticals | 2021-11-30 |
| Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity (NCT05111912) | Sciwind Biosciences APAC CO Pty. Ltd. | 2021-11-30 |
| Practical Anemia Bundle for SusTained Blood Recovery (NCT05167734) | Mayo Clinic | 2021-11-30 |
| Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis (NCT05199337) | K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | 2021-11-30 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) (NCT04988087) | Novartis Pharmaceuticals | 2021-11-30 |
| Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma (NCT05119413) | Centre Hospitalier Universitaire de Nice | 2021-11-30 |